Janus Henderson VIT Overseas Portfolio
Schedule of Investments (unaudited)
September 30, 2020
Shares or | Value | ||||||
Common Stocks– 97.6% | |||||||
Aerospace & Defense – 3.3% | |||||||
CAE Inc | 399,346 | $5,842,917 | |||||
Safran SA* | 144,694 | 14,236,685 | |||||
20,079,602 | |||||||
Banks – 5.8% | |||||||
BNP Paribas SA* | 444,253 | 16,091,538 | |||||
China Construction Bank Corp | 19,450,000 | 12,666,486 | |||||
Erste Group Bank AG* | 201,796 | 4,219,701 | |||||
Permanent TSB Group Holdings PLC* | 3,507,426 | 2,055,478 | |||||
35,033,203 | |||||||
Beverages – 6.7% | |||||||
Diageo PLC | 488,059 | 16,716,872 | |||||
Heineken NV | 267,453 | 23,764,655 | |||||
40,481,527 | |||||||
Biotechnology – 1.0% | |||||||
Ascendis Pharma A/S (ADR)* | 40,936 | 6,317,244 | |||||
Building Products – 2.4% | |||||||
Daikin Industries Ltd | 76,800 | 14,163,214 | |||||
Consumer Finance – 2.0% | |||||||
Nexi SpA (144A)* | 588,431 | 11,798,325 | |||||
Electronic Equipment, Instruments & Components – 2.1% | |||||||
Hexagon AB* | 168,875 | 12,768,238 | |||||
Entertainment – 1.9% | |||||||
Liberty Media Corp-Liberty Formula One* | 121,109 | 4,392,623 | |||||
Nexon Co Ltd | 282,300 | 7,011,869 | |||||
11,404,492 | |||||||
Hotels, Restaurants & Leisure – 4.7% | |||||||
GVC Holdings PLC* | 1,889,192 | 23,773,982 | |||||
Yum China Holdings Inc* | 88,150 | 4,527,046 | |||||
28,301,028 | |||||||
Household Durables – 3.0% | |||||||
Sony Corp | 239,600 | 18,328,392 | |||||
Insurance – 12.4% | |||||||
AIA Group Ltd | 2,466,200 | 24,295,760 | |||||
Beazley PLC | 2,250,203 | 8,891,429 | |||||
Intact Financial Corp | 83,247 | 8,914,945 | |||||
NN Group NV | 502,083 | 18,856,818 | |||||
Prudential PLC | 974,005 | 13,903,002 | |||||
74,861,954 | |||||||
Interactive Media & Services – 6.5% | |||||||
Tencent Holdings Ltd | 586,500 | 39,058,273 | |||||
Internet & Direct Marketing Retail – 6.4% | |||||||
Alibaba Group Holding Ltd* | 1,037,616 | 38,370,894 | |||||
Metals & Mining – 7.5% | |||||||
Antofagasta PLC | 653,878 | 8,619,576 | |||||
Hindustan Zinc Ltd | 3,692,019 | 10,550,753 | |||||
Rio Tinto Ltd | 164,769 | 11,153,159 | |||||
Teck Resources Ltd | 1,050,879 | 14,633,691 | |||||
44,957,179 | |||||||
Oil, Gas & Consumable Fuels – 3.4% | |||||||
Canadian Natural Resources Ltd | 614,939 | 9,845,173 | |||||
Total SE# | 312,252 | 10,719,240 | |||||
20,564,413 | |||||||
Pharmaceuticals – 9.2% | |||||||
AstraZeneca PLC | 185,646 | 20,202,070 | |||||
Novartis AG | 143,257 | 12,452,595 | |||||
Takeda Pharmaceutical Co Ltd | 637,174 | 22,700,627 | |||||
55,355,292 | |||||||
Road & Rail – 0.9% | |||||||
Container Corp Of India Ltd | 1,092,062 | 5,430,247 | |||||
Semiconductor & Semiconductor Equipment – 7.4% | |||||||
ASML Holding NV | 60,136 | 22,171,491 | |||||
Taiwan Semiconductor Manufacturing Co Ltd | 1,481,000 | 22,244,047 | |||||
44,415,538 | |||||||
Specialty Retail – 1.3% | |||||||
Industria de Diseno Textil SA | 286,589 | 7,966,969 | |||||
Technology Hardware, Storage & Peripherals – 3.6% | |||||||
Samsung Electronics Co Ltd | 433,580 | 21,849,957 |
Shares or | Value | ||||||
Common Stocks– (continued) | |||||||
Textiles, Apparel & Luxury Goods – 1.5% | |||||||
Samsonite International SA (144A)* | 8,949,600 | $9,133,381 | |||||
Trading Companies & Distributors – 4.6% | |||||||
Ferguson PLC | 275,003 | 27,664,573 | |||||
Total Common Stocks (cost $483,819,235) | 588,303,935 | ||||||
Investment Companies– 2.2% | |||||||
Money Markets – 2.2% | |||||||
Janus Henderson Cash Liquidity Fund LLC, 0.1028%ºº,£((cost $13,427,417) | 13,426,101 | 13,427,443 | |||||
Investments Purchased with Cash Collateral from Securities Lending– 0% | |||||||
Investment Companies – 0% | |||||||
Janus Henderson Cash Collateral Fund LLC, 0.0289%ºº,£ | 111,485 | 111,485 | |||||
Time Deposits – 0% | |||||||
Canadian Imperial Bank of Commerce, 0.0800%, 10/1/20 | $27,871 | 27,871 | |||||
Total Investments Purchased with Cash Collateral from Securities Lending (cost $139,356) | 139,356 | ||||||
Total Investments (total cost $497,386,008) – 99.8% | 601,870,734 | ||||||
Cash, Receivables and Other Assets, net of Liabilities – 0.2% | 1,257,897 | ||||||
Net Assets – 100% | $603,128,631 |
Summary of Investments by Country - (Long Positions) (unaudited) | |||||
% of | |||||
Investment | |||||
Country | Value | Securities | |||
China | $94,622,699 | 15.7 | % | ||
United Kingdom | 92,106,931 | 15.3 | |||
Netherlands | 64,792,964 | 10.8 | |||
Japan | 62,204,102 | 10.3 | |||
United States | 45,623,995 | 7.6 | |||
France | 41,047,463 | 6.8 | |||
Canada | 39,236,726 | 6.5 | |||
Hong Kong | 33,429,141 | 5.6 | |||
Taiwan | 22,244,047 | 3.7 | |||
South Korea | 21,849,957 | 3.6 | |||
India | 15,981,000 | 2.7 | |||
Sweden | 12,768,238 | 2.1 | |||
Switzerland | 12,452,595 | 2.1 | |||
Italy | 11,798,325 | 2.0 | |||
Australia | 11,153,159 | 1.9 | |||
Spain | 7,966,969 | 1.3 | |||
Denmark | 6,317,244 | 1.0 | |||
Austria | 4,219,701 | 0.7 | |||
Ireland | 2,055,478 | 0.3 |
Total | $601,870,734 | 100.0 | % |
Schedules of Affiliated Investments – (% of Net Assets)
Dividend Income | Realized Gain/(Loss) | Change in Unrealized Appreciation/ Depreciation | Value at 9/30/20 | |||||||
Investment Companies - 2.2% | ||||||||||
Money Markets - 2.2% | ||||||||||
Janus Henderson Cash Liquidity Fund LLC, 0.1028%ºº | $ | 57,015 | $ | (3,741) | $ | 1,150 | $ | 13,427,443 | ||
Investments Purchased with Cash Collateral from Securities Lending - 0.0% | ||||||||||
Investment Companies - 0.0% | ||||||||||
Janus Henderson Cash Collateral Fund LLC, 0.0289%ºº | 178,570∆ | - | - | 111,485 | ||||||
Total Affiliated Investments - 2.2% | $ | 235,585 | $ | (3,741) | $ | 1,150 | $ | 13,538,928 |
Value at 12/31/19 | Purchases | Sales Proceeds | Value at 9/30/20 | |||||||
Investment Companies - 2.2% | ||||||||||
Money Markets - 2.2% | ||||||||||
Janus Henderson Cash Liquidity Fund LLC, 0.1028%ºº | 14,220,778 | 83,673,512 | (84,464,256) | 13,427,443 | ||||||
Investments Purchased with Cash Collateral from Securities Lending - 0.0% | ||||||||||
Investment Companies - 0.0% | ||||||||||
Janus Henderson Cash Collateral Fund LLC, 0.0289%ºº | - | 34,139,496 | (34,028,011) | 111,485 |
Notes to Schedule of Investments (unaudited)
ADR | American Depositary Receipt |
LLC | Limited Liability Company |
PLC | Public Limited Company |
144A | Securities sold under Rule 144A of the Securities Act of 1933, as amended, are subject to legal and/or contractual restrictions on resale and may not be publicly sold without registration under the 1933 Act. Unless otherwise noted, these securities have been determined to be liquid under guidelines established by the Board of Trustees. The total value of 144A securities as of the period ended September 30, 2020 is $20,931,706, which represents 3.5% of net assets. |
* | Non-income producing security. |
ºº | Rate shown is the 7-day yield as of September 30, 2020. |
# | Loaned security; a portion of the security is on loan at September 30, 2020. |
£ | The Portfolio may invest in certain securities that are considered affiliated companies. As defined by the Investment Company Act of 1940, as amended, an affiliated company is one in which the Portfolio owns 5% or more of the outstanding voting securities, or a company which is under common ownership or control. |
∆ | Net of income paid to the securities lending agent and rebates paid to the borrowing counterparties. |
The following is a summary of the inputs that were used to value the Portfolio’s investments in securities and other financial instruments as of September 30, 2020. | ||||||||||||
Valuation Inputs Summary | ||||||||||||
Level 2 - | Level 3 - | |||||||||||
Level 1 - | Other Significant | Significant | ||||||||||
Quoted Prices | Observable Inputs | Unobservable Inputs | ||||||||||
Assets | ||||||||||||
Investments In Securities: | ||||||||||||
Common Stocks | ||||||||||||
Aerospace & Defense | $ | 5,842,917 | $ | 14,236,685 | $ | - | ||||||
Biotechnology | 6,317,244 | - | - | |||||||||
Entertainment | 4,392,623 | 7,011,869 | - | |||||||||
Hotels, Restaurants & Leisure | 4,527,046 | 23,773,982 | - | |||||||||
Insurance | 8,914,945 | 65,947,009 | - | |||||||||
Metals & Mining | 14,633,691 | 30,323,488 | - | |||||||||
Oil, Gas & Consumable Fuels | 9,845,173 | 10,719,240 | - | |||||||||
All Other | - | 381,818,023 | - | |||||||||
Investment Companies | - | 13,427,443 | - | |||||||||
Investments Purchased with Cash Collateral from Securities Lending | - | 139,356 | - | |||||||||
Total Assets | $ | 54,473,639 | $ | 547,397,095 | $ | - | ||||||
Investment Valuation
Securities held by the Portfolio are valued in accordance with policies and procedures established by and under the supervision of the Trustees (the “Valuation Procedures”). Equity securities traded on a domestic securities exchange are generally valued at the closing prices on the primary market or exchange on which they trade. If such price is lacking for the trading period immediately preceding the time of determination, such securities are valued at their current bid price. Equity securities that are traded on a foreign exchange are generally valued at the closing prices on such markets. In the event that there is no current trading volume on a particular security in such foreign exchange, the bid price from the primary exchange is generally used to value the security. Securities that are traded on the over-the-counter (“OTC”) markets are generally valued at their closing or latest bid prices as available. Foreign securities and currencies are converted to U.S. dollars using the applicable exchange rate in effect at the close of the New York Stock Exchange (“NYSE”). The Portfolio will determine the market value of individual securities held by it by using prices provided by one or more approved professional pricing services or, as needed, by obtaining market quotations from independent broker-dealers. Most debt securities are valued in accordance with the evaluated bid price supplied by the pricing service that is intended to reflect market value. The evaluated bid price supplied by the pricing service is an evaluation that may consider factors such as security prices, yields, maturities and ratings. Certain short-term securities maturing within 60 days or less may be evaluated and valued on an amortized cost basis provided that the amortized cost determined approximates market value. Securities for which market quotations or evaluated prices are not readily available or deemed unreliable are valued at fair value determined in good faith under the Valuation Procedures. Circumstances in which fair value pricing may be utilized include, but are not limited to: (i) a significant event that may affect the securities of a single issuer, such as a merger, bankruptcy, or significant issuer-specific development; (ii) an event that may affect an entire market, such as a natural disaster or significant governmental action; (iii) a nonsignificant event such as a market closing early or not opening, or a security trading halt; and (iv) pricing of a nonvalued security and a restricted or nonpublic security. Special valuation considerations may apply with respect to “odd-lot” fixed-income transactions which, due to their small size, may receive evaluated prices by pricing services which reflect a large block trade and not what actually could be obtained for the odd-lot position. The Portfolio uses systematic fair valuation models provided by independent third parties to value international equity securities in order to adjust for stale pricing, which may occur between the close of certain foreign exchanges and the close of the NYSE.
Valuation Inputs Summary
FASB ASC 820, Fair Value Measurements and Disclosures (“ASC 820”), defines fair value, establishes a framework for measuring fair value, and expands disclosure requirements regarding fair value measurements. This standard emphasizes that fair value is a market-based measurement that should be determined based on the assumptions that market participants would use in pricing an asset or liability and establishes a hierarchy that prioritizes inputs to valuation techniques used to measure fair value. These inputs are summarized into three broad levels:
Level 1 – Unadjusted quoted prices in active markets the Portfolio has the ability to access for identical assets or liabilities.
Level 2 – Observable inputs other than unadjusted quoted prices included in Level 1 that are observable for the asset or liability either directly or indirectly. These inputs may include quoted prices for the identical instrument on an inactive market, prices for similar instruments, interest rates, prepayment speeds, credit risk, yield curves, default rates and similar data.
Assets or liabilities categorized as Level 2 in the hierarchy generally include: debt securities fair valued in accordance with the evaluated bid or ask prices supplied by a pricing service; securities traded on OTC markets and listed securities for which no sales are reported that are fair valued at the latest bid price (or yield equivalent thereof) obtained from one or more dealers transacting in a market for such securities or by a pricing service approved by the Portfolio’s Trustees; certain short-term debt securities with maturities of 60 days or less that are fair valued at amortized cost; and equity securities of foreign issuers whose fair value is determined by using systematic fair valuation models provided by independent third parties in order to adjust for stale pricing which may occur between the close of certain foreign exchanges and the close of the NYSE. Other securities that may be categorized as Level 2 in the hierarchy include, but are not limited to, preferred stocks, bank loans, swaps, investments in unregistered investment companies, options, and forward contracts.
Level 3 – Unobservable inputs for the asset or liability to the extent that relevant observable inputs are not available, representing the Portfolio’s own assumptions about the assumptions that a market participant would use in valuing the asset or liability, and that would be based on the best information available.
There have been no significant changes in valuation techniques used in valuing any such positions held by the Portfolio since the beginning of the fiscal year.
The inputs or methodology used for fair valuing securities are not necessarily an indication of the risk associated with investing in those securities. The summary of inputs used as of September 30, 2020 to fair value the Portfolio’s investments in securities and other financial instruments is included in the “Valuation Inputs Summary” in the Notes to Schedule of Investments.
For additional information on the Portfolio, please refer to the Portfolio’s most recent semiannual or annual shareholder report.